🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04094428
Recruiting Observational

Burden, Mortality and Supply Costs in Intensive Care Unit Patients

NCT04094428 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2019-10-21
Last updated
2024-01-17

Condition(s) studied

Burden, DependencyMortalityEnd-of-life CareIntensive Care UnitCritically Ill PatientFrailtyMultiple Organ Failure

Study summary

This study systematically observes in a pragmatic trail under real world conditions the association between strategies of therapy (maximal therapy, withhold, withdraw) and treatment success in three endpoint related initial risk groups (high, intermediate, low risk) regarding three endpoints (burden, mortality and supply costs).

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * All patients dying on the ICU and all patients staying for at least 72 hours on the ICU Exclusion Criteria: * No

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Anaesthesiology, University Hospital Ulm Ulm Germany Recruiting

More University of Ulm trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04094428 on ClinicalTrials.gov ↗ ← All trials in Germany